In this final part of a recent interview with Jonathan Strober, MD, UCSF Benioff Children's Hospital and phase 2/3 ...

The FDA has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis in patients aged 12 years and older who are AChR or anti-muscle-specific tyrosine kinase antibody ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Earlier this year, nipocalimab data from Vivacity-MG3 supported the medication's long-term use in generalized myasthenia gravis when it ... causing the symptoms. The antibodies, which attack ...

Myasthenia gravis (MG) is a rare ... The researchers tracked body weight, muscle strength, fatigue resistance, and antibody levels. They found that JYBP significantly improved symptoms and ...

Myasthenia gravis (MG) should be classified according to antibody status (acetylcholine, MuSK, LRP4, titin), thymus (hyperplasia, neoplasia, atrophy), age at debut (< or >50 years), symptom ...

MYASTHENIA gravis has frequently been described as a clinical entity. It is a disease characterized by abnormal skeletal-muscle fatigability. The cause is unknown. The myoneural junction seems to ...

Winnacunnet High School senior Joe LaBrecque was diagnosed with myasthenia gravis, a rare neuromuscular autoimmune disorder. LaBrecque is raising awareness about the disease and participating in ...

In its fourth-quarter results update, Sanofi said it had discontinued the phase 3 URSA trial of tolebrutinib in patients with moderate-to-severe myasthenia gravis, but stressed the decision was ...

Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG ... receptor (AChR) antibody-positive. UCB also notes that ...

said the company’s work around the launch of the prefilled syringe reflects discussions with generalized myasthenia gravis (gMG) patients. “We listened to the voices of patients in the gMG ...

Engineering an antibody against flu with sticky staying power Aerosol treatment adheres to lung lining, blocks infection in mice Date: May 8, 2025 Source: Ohio State University Summary: Scientists ...